Pan-Euro Pharma Primer: 'protein strangling' (ATTR): why should AZN lead in this $20bn peak cardio market?
Bernstein (Sanford C. Bernstein)2026-07-0638 页
Annual Completed Clinical Trials Report
Citeline (Pharma Intelligence UK Limited)2026-07-1538 页
Longitudinal Access and Adjudication Data (LAAD) — Product Definition
IQVIA2026-07-168 页